November 16, 2018
The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 16 November 2018 it purchased 500,000 Ordinary Shares of 1p in the capital of the Company ("Ordinary Shares") at 3.42p per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 62,946,734 equivalent to 21.32% of Proteome Sciences' total issued share capital.